Anavex Life Sciences Corp (NASDAQ:AVXL)

16.94
Delayed Data
As of 3:59pm ET
 -0.13 / -0.76%
Today’s Change
3.75
Today|||52-Week Range
31.50
+213.70%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues0.000.000.000.00--
 
Operating ExpensesGross Income0.000.000.000.00--
General Expenses5.9M7.5M8.1M7.1M
 
 
 
 
 
Research And Development4.4M5.7M6.1M5.8M
 
 
 
 
 
Total Operating Expenses5.9M7.5M8.1M7.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.9M-7.5M-8.1M-7.1M
 
 
 
 
 
Extraordinary Credit0.000.000.0037.0K
 
 
Other Expenses-27.0K-4.5K54.2K-54.6K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.8M-7.3M-8.0M-7.1M
 
 
 
 
 
Income Taxes-35.5K-8.7K-48.0K-19.3K
 
 
 
 
 
Net Income-5.8M-7.3M-8.0M-7.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS45.9M46.3M47.1M49.6M
 
 
 
 
 
Shares To Calculate EPS Diluted45.9M46.3M47.1M49.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.13-$0.16-$0.17-$0.14
 
 
 
 
 
EPS Diluted-$0.13-$0.16-$0.17-$0.14